![Elisabeth Leiderman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Elisabeth Leiderman
Director/Board Member at
AUTOLUS THERAPEUTICS PLC
Net worth: - $ as of 31/05/2026
Profile
Elisabeth Leiderman currently works at Autolus Therapeutics Plc, as Non-Executive Director from 2023 and Dewpoint Therapeutics, Inc., as Chief Financial Officer from 2024.
Dr. Leiderman also formerly worked at bluebird bio, Inc., as Independent Director from 2021 to 2025, Nomura Securities, Inc., as Executive Director from 2013 to 2016, Fortress Biotech, Inc., as VP-Business & Corporate Development from 2007 to 2016, Complexa, Inc., as Chief Business Officer from 2016 to 2020, Decibel Therapeutics, Inc., as Chief Financial & Accounting Officer from 2021 to 2022, and Atsena Therapeutics, Inc., as Chief Financial & Business Officer from 2022 to 2023.
Dr. Leiderman received her undergraduate degree from the University of Pennsylvania, Masters Business Admin degree from The Wharton School of the University of Pennsylvania, and doctorate degree from Sackler School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 18/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Elisabeth Leiderman active positions
| Companies | Position | Start |
|---|---|---|
| AUTOLUS THERAPEUTICS PLC | Director/Board Member | 20/12/2023 |
Dewpoint Therapeutics, Inc.
 Dewpoint Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biomolecular condensates biotechnology company | Director of Finance/CFO | 01/06/2024 |
Former positions of Elisabeth Leiderman
| Companies | Position | End |
|---|---|---|
| GENETIX BIOTHERAPEUTICS, INC. | Director/Board Member | 02/06/2025 |
Atsena Therapeutics, Inc.
 Atsena Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical-stage gene therapy company that develops treatments for inherited retinal diseases that cause blindness | Director of Finance/CFO | 01/11/2023 |
| DECIBEL THERAPEUTICS, INC. | Director of Finance/CFO | 07/10/2022 |
Complexa, Inc.
 Complexa, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on discovering and developing therapies for the treatment inflammatory and metabolic diseases | Corporate Officer/Principal | 01/08/2020 |
Nomura Securities, Inc. | Director/Board Member | 01/07/2016 |
Training of Elisabeth Leiderman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
33
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Fortress Biotech, Inc.
 Fortress Biotech, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical and biotechnology products | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
bluebird bio, Inc.
 bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
Complexa, Inc.
Complexa, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on discovering and developing therapies for the treatment inflammatory and metabolic diseases | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sackler School of Medicine
 Sackler School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Decibel Therapeutics, Inc.
 Decibel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines for hearing and balance disorders | Health Technology |
Autolus Therapeutics Plc
 Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
Dewpoint Therapeutics, Inc.
Dewpoint Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biomolecular condensates biotechnology company | Health Technology |
Atsena Therapeutics, Inc.
Atsena Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical-stage gene therapy company that develops treatments for inherited retinal diseases that cause blindness | Health Technology |
Nomura Securities, Inc. |
- Stock Market
- Insiders
- Elisabeth Leiderman
